Aprepitant Accord 125 mg/80 mg hard capsules Ireland - English - HPRA (Health Products Regulatory Authority)

aprepitant accord 125 mg/80 mg hard capsules

accord healthcare ireland ltd. - aprepitant; aprepitant - capsule, hard - 80/125 milligram(s) - aprepitant

Atanto 125 mg + 80 mg hard caps. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

atanto 125 mg + 80 mg hard caps.

pharmathen s.a. - aprepitant 80 mg (white/white capsule, hard); aprepitant 125 mg (pink/white capsule, hard) - capsule, hard - 125 mg + 80 mg - aprepitant 80 mg; aprepitant 125 mg - aprepitant

Aprepitant 80mg capsules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

aprepitant 80mg capsules

sandoz ltd - aprepitant - oral capsule - 80mg

Aprepitant 80mg capsules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

aprepitant 80mg capsules

accord-uk ltd - aprepitant - oral capsule - 80mg

Aprepitant 80mg capsules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

aprepitant 80mg capsules

a a h pharmaceuticals ltd - aprepitant - oral capsule - 80mg

Emend New Zealand - English - Medsafe (Medicines Safety Authority)

emend

merck sharp & dohme (new zealand) limited - aprepitant 80mg - capsule - 80 mg - active: aprepitant 80mg excipient: gelatin hyprolose microcrystalline cellulose sodium laurilsulfate sucrose - emend, in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of: · moderately emetogenic cancer chemotherapy. · highly emetogenic cancer chemotherapy.

Aprepitant Rontis Capsules Hard 80mg Malta - English - Medicines Authority

aprepitant rontis capsules hard 80mg

rontis hellas medical and pharmaceutical products s.a. 38, sorou str., athens, maroussi, 15125, greece - aprepitant - hard capsule - aprepitant 80 mg - antiemetics and antinauseants

Atanto 80 mg hard caps. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

atanto 80 mg hard caps.

pharmathen s.a. - aprepitant 80 mg - capsule, hard - 80 mg - aprepitant 80 mg - aprepitant

EMEND IV fosaprepitant 150mg (as fosaprepitant dimeglumine) powder for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

emend iv fosaprepitant 150mg (as fosaprepitant dimeglumine) powder for injection vial

merck sharp & dohme (australia) pty ltd - fosaprepitant dimeglumine, quantity: 257.6 mg (equivalent: fosaprepitant, qty 150 mg) - injection, powder for - excipient ingredients: disodium edetate; sodium hydroxide; hydrochloric acid; polysorbate 80; lactose - emend iv, in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of: - highly emetogenic cancer chemotherapy (see dosage and administration); - moderately emetogenic cancer chemotherapy (see dosage and administration).

FOSAPREPITANT MSN fosaprepitant (as dimeglumine) 150 mg powder for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

fosaprepitant msn fosaprepitant (as dimeglumine) 150 mg powder for injection vial

reach pharmaceuticals pty ltd - fosaprepitant dimeglumine, quantity: 245.3 mg (equivalent: fosaprepitant, qty 150 mg) - injection, powder for - excipient ingredients: lactose; polysorbate 80; hydrochloric acid; sodium hydroxide; disodium edetate - fosaprepitant msn, in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of:,? highly emetogenic cancer chemotherapy (see section 4.2 dose and method of administration),? moderately emetogenic cancer chemotherapy (see section 4.2 dose and method of administration).